William-ONG

William ONG, PhD

Technical Analyst

William leverages on his strong scientific background to evaluate the technology and IP of many young companies.

Prior to Ginward, William invented a unique drug screening platform for demyelinating diseases to remove the need for animal testing. William also engineered an artificial axon platform, which models dysregulation in the central nervous system mechanical environment as a result of traumatic injuries and disorders. He was among a group of pioneering scientists to demonstrate the pivotal role of mechanical stiffness in the central nervous system myelination. He worked with renowned international researchers from top universities and research institutions in Singapore, US, UK and China.

William’s contribution to the central nervous system research is evident in 9 tier-1 academic publications, including lead authorships in top international journals such as Acta Biomaterialia and Advanced Drug Delivery Reviews. He was invited to speak at the Gordon Research Conferences in Los Angeles and TERMIS Asia Pacific in Taipei on his inventions.

William was awarded the prestigious ASEAN Scholarship and ASEAN Undergraduate Scholarship from 2005 to 2015 by the Ministry of Education, Singapore. He worked for GSK Singapore in the engineering services department and earned the CFA Institute Investment Foundations certificate.

He holds a Ph.D. in Biomedical Sciences and Engineering, Research Scholar from Nanyang Technological University as well as Bachelor’s in Chemical Engineering with First Class honours.

Edward Willems

Edward WILLEMS

Managing Director & Co-founder

Ginger Hsiao

Ginger HSIAO

Co-founder

Shang Hsiao

Shang HSIAO

Co-founder and Venture Partner

Fumiaki YUMOTO, PhD

Country Head Japan, Managing Director

Jaap Weiling

Jaap WIELING

Venture Partner and Scientific Advisor

Eric Woo

Eric WOO

Technical Analyst

Nithya

Nithya ALAGAPPAN

Technical Analyst

Ha Linh NGUYEN

Technical Analyst

Gary Teo

Financial Analyst

Dr. Bert Tjeenk Willink

Advisor and Venture Partner

Andrew Lin

Andrew LIN

Advisor

Clark Su

Clark SU

Advisor

Adam Kirby

Adam KIRBY

Advisor

Jerry Hong

Jerry HONG

Advisor